Zoetis posts Q3 2026 results, narrows revenue guidance, raises EPS outlook
Zoetis reported third-quarter revenue of $2.4 billion, down 1%, while flagging pipeline approvals including Convenia RTU for Dogs and an EUA for Simparica Trio against screwworm.
SEC filing